Immediate Impact
60 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Kanqiu Jiang being referenced
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kanqiu Jiang | 234 | 122 | 114 | 15 | 389 | |
| Tianxiu Dong | 201 | 91 | 99 | 19 | 358 | |
| Lanya Li | 270 | 126 | 74 | 11 | 410 | |
| Zeqian Yu | 199 | 118 | 170 | 17 | 352 | |
| Fan Yang | 259 | 87 | 116 | 20 | 398 | |
| Caterina Bartolacci | 218 | 78 | 76 | 15 | 337 | |
| Sunsook Hwang | 181 | 89 | 166 | 15 | 348 | |
| Seong‐Min Kwon | 203 | 54 | 57 | 14 | 416 | |
| Fuqiang Feng | 242 | 72 | 122 | 19 | 423 | |
| André Wendindondé Nana | 156 | 135 | 84 | 12 | 352 | |
| Vahideh Zarrin | 231 | 87 | 150 | 8 | 390 |
All Works
Login with ORCID to disown or claim papers
Loading papers...